Monitoring ORKA open interest helps you see where real money is positioned on Oruka Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Oruka Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ORKA options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ORKA options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Oruka Therapeutics Inc to settle.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ORKA open interest is concentrated. Our scanner maps Oruka Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Oruka Therapeutics Inc's options open interest as the signal it is, not as an afterthought.
